{"id":21637,"date":"2024-12-09T10:47:10","date_gmt":"2024-12-09T10:47:10","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/?p=21637"},"modified":"2024-12-09T10:50:09","modified_gmt":"2024-12-09T10:50:09","slug":"21637","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/","title":{"rendered":"EIPG&#8217;s Newsletter: November edition"},"content":{"rendered":"<p>The <strong>European Industrial Pharmacists Group <\/strong>(<strong><a href=\"https:\/\/www.eipg.eu\/\" target=\"_blank\" rel=\"noopener\">EIPG<\/a><\/strong>) presents its <strong>November newsletter<\/strong>, offering a comprehensive update on the latest developments and opportunities in the pharmaceutical and healthcare industries. This regular publication is an essential resource for staying informed about regulatory changes, research initiatives, and educational opportunities tailored for EIPG members.<\/p>\n<p>Highlights in this edition include:<\/p>\n<ul>\n<li><strong>Mario Draghi&#8217;s Report:<\/strong> A focus on strategies to close the EU innovation gap with the US and China through systemic reforms, decarbonization, and robust supply chain management.<\/li>\n<li><strong>EU Supply Chain Law:<\/strong> Details on the CSDDD directive and its implications for environmental and human rights monitoring across value chains, set for gradual implementation from 2027.<\/li>\n<li><strong>ACT-EU Initiative:<\/strong> Updates on the transformation of clinical trials in the EU, with emphasis on safer drug development and modern methodologies.<\/li>\n<li><strong>Future R&amp;D Programs:<\/strong> Insights into the post-2024 EU election agenda, featuring Horizon Europe 2025 and FP10, focusing on innovation, sustainability, and increased investment in research.<\/li>\n<\/ul>\n<p>EIPG members also benefit from exclusive discounts on training modules, such as the on-demand course on EU GMP Annex 1 compliance.<\/p>\n<p>Don&#8217;t miss out on opportunities for professional growth and insight into industry advancements. <a href=\"https:\/\/www.linkedin.com\/company\/european-industrial-pharmacists-group\/?viewAsMember=true\" target=\"_blank\" rel=\"noopener\">Stay connected with EIPG<\/a> for regular updates and access to dedicated information and training opportunities.<\/p>\n<div id=\"tw-target-text-container\" class=\"tw-ta-container F0azHf tw-nfl\" tabindex=\"0\" role=\"text\">\n<p id=\"tw-target-text\" class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Traduzione\" data-ved=\"2ahUKEwiq667NvpqKAxVGh_0HHQrKMrYQ3ewLegQICxAU\" aria-label=\"Testo tradotto: Read the newsletter\"><span class=\"Y2IQFc\" lang=\"en\">Read the newsletter: <\/span><a href=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/Newsletter-eipg_November_2024_new.pdf\">Newsletter eipg_November_2024_new<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The European Industrial Pharmacists Group (EIPG) has released its November 2024 newsletter, providing updates on EU innovation strategies, supply chain laws, clinical trial transformations, and future R&#038;D programs. Members receive exclusive training discounts. Stay connected with EIPG for ongoing professional development opportunities.<\/p>\n","protected":false},"author":32,"featured_media":21643,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[687],"tags":[],"class_list":{"0":"post-21637","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-eipg-news"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EIPG&#039;s Newsletter: November edition - MakingPharmaIndustry<\/title>\n<meta name=\"description\" content=\"Updates on EU innovation strategies, supply chain laws, clinical trial transformations, and future R&amp;D programs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EIPG&#039;s Newsletter: November edition - MakingPharmaIndustry\" \/>\n<meta property=\"og:description\" content=\"Updates on EU innovation strategies, supply chain laws, clinical trial transformations, and future R&amp;D programs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-09T10:47:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-09T10:50:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1076467037-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1435\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09\"},\"headline\":\"EIPG&#8217;s Newsletter: November edition\",\"datePublished\":\"2024-12-09T10:47:10+00:00\",\"dateModified\":\"2024-12-09T10:50:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/\"},\"wordCount\":215,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1076467037-scaled.jpeg\",\"articleSection\":[\"EIPG NEWS\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/\",\"name\":\"EIPG's Newsletter: November edition - MakingPharmaIndustry\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1076467037-scaled.jpeg\",\"datePublished\":\"2024-12-09T10:47:10+00:00\",\"dateModified\":\"2024-12-09T10:50:09+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09\"},\"description\":\"Updates on EU innovation strategies, supply chain laws, clinical trial transformations, and future R&D programs.\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1076467037-scaled.jpeg\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1076467037-scaled.jpeg\",\"width\":2560,\"height\":1435},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EIPG&#8217;s Newsletter: November edition\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EIPG's Newsletter: November edition - MakingPharmaIndustry","description":"Updates on EU innovation strategies, supply chain laws, clinical trial transformations, and future R&D programs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/","og_locale":"en_US","og_type":"article","og_title":"EIPG's Newsletter: November edition - MakingPharmaIndustry","og_description":"Updates on EU innovation strategies, supply chain laws, clinical trial transformations, and future R&D programs.","og_url":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2024-12-09T10:47:10+00:00","article_modified_time":"2024-12-09T10:50:09+00:00","og_image":[{"width":2560,"height":1435,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1076467037-scaled.jpeg","type":"image\/jpeg"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09"},"headline":"EIPG&#8217;s Newsletter: November edition","datePublished":"2024-12-09T10:47:10+00:00","dateModified":"2024-12-09T10:50:09+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/"},"wordCount":215,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1076467037-scaled.jpeg","articleSection":["EIPG NEWS"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/","url":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/","name":"EIPG's Newsletter: November edition - MakingPharmaIndustry","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1076467037-scaled.jpeg","datePublished":"2024-12-09T10:47:10+00:00","dateModified":"2024-12-09T10:50:09+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09"},"description":"Updates on EU innovation strategies, supply chain laws, clinical trial transformations, and future R&D programs.","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1076467037-scaled.jpeg","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1076467037-scaled.jpeg","width":2560,"height":1435},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/eipg-news\/21637\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"EIPG&#8217;s Newsletter: November edition"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=21637"}],"version-history":[{"count":4,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21637\/revisions"}],"predecessor-version":[{"id":21648,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21637\/revisions\/21648"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/21643"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=21637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=21637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=21637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}